BusinessMaricann Group's Green Approach - An Investment in Our Future -- CFN MediaBy Nasdaq OMXMay 8, 2018, 12:44 PM UTC
BusinessRelypsa Announces FDA Approval of Supplemental New Drug Application to Enable the Usage of Veltassa® (patiromer) With or Without FoodBy Nasdaq OMXMay 8, 2018, 12:01 PM UTC
BusinessExosome Diagnostics Expands National Sales Team after Blockbuster Quarter with its Flagship Diagnostic, ExoDx Prostate®(IntelliScore) (EPI) TestBy Nasdaq OMXMay 8, 2018, 10:30 AM UTC
BusinessInvivoscribe Submits Pre-Market Approval Application in Japan and Panel Track Supplement in the US to Screen Acute Myeloid Leukemia (AML) Patients for FLT3 MutationsBy Nasdaq OMXMay 8, 2018, 10:01 AM UTC
BusinessCarepoynt Exhibits at HLTH After Winning American Business Award® for Start-Up of the YearBy Nasdaq OMXMay 7, 2018, 4:42 PM UTC
BusinessLandmark Study Shows GeneSight® Test Led to Significant Improvement in Mental Health Outcomes for Patients with Major Depressive DisorderBy Nasdaq OMXMay 7, 2018, 11:05 AM UTC
BusinessLexaria Solidifies Presence in Edibles Market with New Agreement -- CFN MediaBy Nasdaq OMXMay 4, 2018, 12:44 PM UTC
